F-1/A: Auna S.A. Files for IPO, Aiming to Transform Latin American Healthcare

Auna S.A., a Luxembourg-based healthcare company, has filed an amendment to its F-1 registration statement for an initial public offering (IPO) of its Class A ordinary shares on the New York Stock Exchange (NYSE) under the symbol AUNA.

Summary

• Auna S.A., incorporated in the Grand Duchy of Luxembourg, is pursuing an IPO to offer Class A ordinary shares.
• The company has applied to list its Class A shares on the NYSE under the symbol 'AUNA'.
• The preliminary prospectus, dated February 22, 2024, indicates an anticipated IPO price between two undisclosed USD values per Class A share.
• Underwriters have a 30-day option to purchase additional Class A shares at the IPO price, less discounts and commissions.
• Upon completion of the offering, Auna will have Class A and Class B ordinary shares, differing in nominal value, voting, and conversion rights.
• Each Class A share carries one vote, while each Class B share carries ten votes.
• Post-IPO, Enfoca, the controlling shareholder, will own approximately 72.9% of Class B shares, representing a significant portion of the combined voting power.
• The dual-class structure concentrates voting control with Enfoca, potentially limiting other shareholders' influence.
• Auna is an emerging growth company and will be subject to reduced public company reporting requirements.
• The company does not provide any activity as foreseen by the Luxembourg Law of April 5, 1993 in the financial sector, as amended, and the Luxembourg Law of 10 November 2009 on payment services.
• The company does not have any license with respect to the abovementioned laws and activities.

Sentiment

Score: 7

Explanation: The document is a standard IPO filing, presenting both opportunities and risks. The company's growth potential in Latin America is promising, but the dual-class structure and emerging growth company status introduce some uncertainty.

Positives

• The company is pursuing an IPO to raise capital.
• The company aims to list on the NYSE, which could increase its visibility and access to capital.
• The company is an emerging growth company, which allows it to take advantage of reduced reporting requirements.

Negatives

• The dual-class structure concentrates voting control with Enfoca, potentially limiting other shareholders' influence.
• The company is an emerging growth company, which may make its shares less attractive to some investors.

Risks

• The dual-class structure of our shares, as well as the classified structure of our board of directors, have the effect of concentrating voting control with Enfoca or its shareholders and limiting our other shareholders ability to influence corporate matters.
• Neither the class A shares nor the offering have been or will be registered in the Grand Duchy of Luxembourg and therefore neither the class A shares nor the offering are or will be subject to Luxembourg laws applicable to public offerings in Luxembourg.
• The class A shares may not be offered or sold in Luxembourg except in compliance with the securities laws of Luxembourg.
• Investing in our class A shares involves risks.

Future Outlook

Auna intends to use the net proceeds from this offering to (i) fund the repayment by our shareholders of their Sponsor Financing, (ii) repay the Term Loans and (iii) for other general corporate purposes.

Industry Context

This IPO filing comes amid increasing investor interest in the healthcare sector, particularly in companies focused on emerging markets. Auna's focus on Spanish-speaking Latin America positions it to capitalize on the growing demand for quality healthcare services in the region.

Stakeholder Impact

• Shareholders: Potential for capital appreciation, but limited influence due to dual-class structure.
• Employees: Potential for growth and career opportunities within the company.
• Customers: Increased access to healthcare services and potential for improved quality of care.
• Suppliers: Potential for increased business opportunities with a growing company.

Next Steps

• The company will proceed with the IPO process, including pricing and allocation of shares.
• The company will work to secure a listing on the NYSE.
• The company will use the proceeds from the IPO to repay debt and fund future growth.

Key Dates

Keywords

IPO, Auna S.A., Class A ordinary shares, NYSE, Enfoca, Emerging growth company, Dual-class structure, Luxembourg